Bristol-Myers Squibb Co header image

Bristol-Myers Squibb Co

BMY

Equity

ISIN null / Valor 914188

New York Stock Exchange, Inc (2026-10-30)
USD 62.48+1.78%

Bristol-Myers Squibb Co
UMushroom community rating:

star star star star star
4.00 2 votes No rating yet
NegativeNeutralPositive

About company

Bristol-Myers Squibb is a global biopharmaceutical company that researches, develops, manufactures and commercializes prescription medicines, with a commercial focus on oncology, hematology, immunology and cardiovascular disease. Its marketed portfolio includes immuno‑oncology therapies such as nivolumab (Opdivo), the widely used anticoagulant apixaban (Eliquis, co‑developed with Pfizer) and a range of treatments for blood cancers and autoimmune conditions, while its pipeline covers targeted small molecules, biologics and emerging modalities including cell therapies. The company generates revenue from global product sales, licensing and collaboration agreements and supports those commercial activities with substantial R&D and clinical development operations; its 2019 acquisition of Celgene significantly expanded its hematology and oncology franchises. Headquartered in New York, Bristol‑Myers Squibb operates worldwide as a publicly traded pharmaceutical firm.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

37.0%1Y
21.9%3Y
6.99%5Y

Performance

27.2%1Y
28.0%3Y
24.8%5Y

Volatility

Market cap

127714 M

Market cap (USD)

Daily traded volume (Shares)

12,668,093

Daily traded volume (Shares)

1 day high/low

57.55 / 56.05

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

2 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Nojus Okleiteris
Netherlands, 09 Nov 2025
star star star star star
.
Markus Dathe
Switzerland, 28 Mar 2025
star star star star star
Big Pharma.

EQUITIES OF THE SAME SECTOR

Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.97%USD 18.94
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc Xenon Pharmaceuticals Inc Valor: 25419823
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.35%USD 37.41
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc West Pharmaceutical Services Inc Valor: 112491
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.97%USD 412.62
Zydus Lifesciences Limited
Zydus Lifesciences Limited Zydus Lifesciences Limited Valor: 29835501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.89%INR 1,244.00
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Ltd. Narayana Hrudayalaya Ltd. Valor: 30795490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.32%INR 1,719.70
Molina Healthcare Inc
Molina Healthcare Inc Molina Healthcare Inc Valor: 1538184
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.93%USD 204.78
Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited Valor: 30691066
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%INR 1,906.30
CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%USD 82.22
Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.57%USD 92.01
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc Zimmer Biomet Holdings Inc Valor: 1262932
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.03%USD 94.52